Atara Biotherapeutics (ATRA) Asset Writedowns and Impairment (2025)
Atara Biotherapeutics (ATRA) reported Asset Writedowns and Impairment of $4.1 million for Q1 2025.
Atara Biotherapeutics (ATRA) Asset Writedowns and Impairment (2025) Analysis & Trends
Atara Biotherapeutics has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $4.1 million in Q1 2025.
- For the quarter ending Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (changed N/A YoY), and the FY2025 full-year result was $4.1 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at $4.1 million.
- The five-year high for Asset Writedowns and Impairment was $4.1 million in Q1 2025, with the low at $4.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.13 Mn |
| Mar 31, 2025 | 4.13 Mn |